SCHOLAR ROCK HOLDING CORPORATION Other Noncash Income (Expense)
SCHOLAR ROCK HOLDING CORPORATION (SRRK) reported Other Noncash Income (Expense) of -$95.00 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2018-11-08
- SCHOLAR ROCK HOLDING CORPORATION other noncash income (expense) for the quarter ending 2018-09-30 was -$13.00K.
- SCHOLAR ROCK HOLDING CORPORATION other noncash income (expense) for the quarter ending 2017-09-30 was $0.00.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 9 month |
|---|---|---|---|
| 2018-09-30 | -$13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$95.00K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | -$82.00K 10-Q · filed 2018-08-08 | ||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$35.00K 10-Q · filed 2018-11-08 | |
| 2017-06-30 | -$35.00K 10-Q · filed 2018-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |